BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25598440)

  • 21. An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
    Beattie D; Beer D; Bradley ME; Bruce I; Charlton SJ; Cuenoud BM; Fairhurst RA; Farr D; Fozard JR; Janus D; Rosethorne EM; Sandham DA; Sykes DA; Trifilieff A; Turner KL; Wissler E
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6280-5. PubMed ID: 22932315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.
    Usmani OS; Ito K; Maneechotesuwan K; Ito M; Johnson M; Barnes PJ; Adcock IM
    Am J Respir Crit Care Med; 2005 Sep; 172(6):704-12. PubMed ID: 15860753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid effects on the beta-adrenergic receptor-adenylyl cyclase system of human airway epithelium.
    Aksoy MO; Mardini IA; Yang Y; Bin W; Zhou S; Kelsen SG
    J Allergy Clin Immunol; 2002 Mar; 109(3):491-7. PubMed ID: 11897997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation.
    Lee SU; Ahn KS; Sung MH; Park JW; Ryu HW; Lee HJ; Hong ST; Oh SR
    Mol Cells; 2014 Aug; 37(8):585-91. PubMed ID: 25134539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation.
    Kobayashi Y; Mercado N; Miller-Larsson A; Barnes PJ; Ito K
    Pulm Pharmacol Ther; 2012 Jun; 25(3):201-7. PubMed ID: 22401993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells.
    LeVan TD; Babin EA; Yamamura HI; Bloom JW
    Biochem Pharmacol; 1999 May; 57(9):1003-9. PubMed ID: 10796070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.
    Sayers I; Hawley J; Stewart CE; Billington CK; Henry A; Leighton-Davies JR; Charlton SJ; Hall IP
    Br J Pharmacol; 2009 Sep; 158(1):277-86. PubMed ID: 19422388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.
    Scola AM; Loxham M; Charlton SJ; Peachell PT
    Br J Pharmacol; 2009 Sep; 158(1):267-76. PubMed ID: 19371332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and clinical profile of indacaterol maleate (Onbrez®), an inhaled long-acting β₂-adrenoceptor agonist].
    Suzuki K; Uchiyama M; Matsushima S; Yoshiki M; Kitawaki T
    Nihon Yakurigaku Zasshi; 2012 Jul; 140(1):36-43. PubMed ID: 22790232
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma.
    Klaßen C; Karabinskaya A; Dejager L; Vettorazzi S; Van Moorleghem J; Lühder F; Meijsing SH; Tuckermann JP; Bohnenberger H; Libert C; Reichardt HM
    J Immunol; 2017 Jul; 199(1):48-61. PubMed ID: 28515280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
    Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
    Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
    Naline E; Trifilieff A; Fairhurst RA; Advenier C; Molimard M
    Eur Respir J; 2007 Mar; 29(3):575-81. PubMed ID: 17135231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of the glucocorticoid hormone receptor with plasmid DNA comprising glucocorticoid response elements improves nonviral gene transfer efficiency in the lungs of mice.
    Dames P; Laner A; Maucksch C; Aneja MK; Rudolph C
    J Gene Med; 2007 Sep; 9(9):820-9. PubMed ID: 17668918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment.
    Desmet SJ; Bougarne N; Van Moortel L; De Cauwer L; Thommis J; Vuylsteke M; Ratman D; Houtman R; Tavernier J; De Bosscher K
    Sci Rep; 2017 Aug; 7(1):8063. PubMed ID: 28808239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human lens epithelial cells.
    Gupta V; Galante A; Soteropoulos P; Guo S; Wagner BJ
    Mol Vis; 2005 Nov; 11():1018-40. PubMed ID: 16319822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abediterol (LAS100977), an inhaled long-acting β
    Ramos I; Aparici M; Letosa M; Puig C; Gavaldà A; Huerta JM; Espinosa S; Vilella D; Miralpeix M
    Eur J Pharmacol; 2018 Jan; 819():89-97. PubMed ID: 29183838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells.
    Chen Y; Nickola TJ; DiFronzo NL; Colberg-Poley AM; Rose MC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):338-47. PubMed ID: 16239644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.